Continue to opt for HDT/ASCT for multiple myelomaJanuary 5, 2018Multiple MyelomaHematologic Malignancies
Higher Risk of Secondary Cancers for Patients With Mycosis FungoidesDecember 14, 2017Hematologic Malignancies
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Hematologic MalignanciesMultiple Myeloma
FDA approves first gene therapy – tisagenlecleucel for ALLAugust 30, 2017Hematologic MalignanciesImmuno-oncology
The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA (FULL)August 4, 2017Hematologic MalignanciesImmuno-oncology
Which Acute Myeloid Leukemia Patients are Good Immunotherapy Candidates?August 1, 2017Hematologic Malignancies
Evaluation of Fitness, Metabolism, and Quality of Life During Hematopoietic Stem Cell TransplantAugust 1, 2017Hematologic Malignancies
Characterization of Hematology Consults for Complete Blood Count Abnormalities: A Single Center Experience in the Era of Electronic ConsultationAugust 1, 2017Hematologic Malignancies
Less lenalidomide may be more in frail elderly multiple myeloma patientsJuly 27, 2017Hematologic MalignanciesMultiple Myeloma
